Division of Clinical and Molecular Endocrinology, UH-Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Endocrine. 2019 Jan;63(1):140-148. doi: 10.1007/s12020-018-1769-z. Epub 2018 Sep 27.
Patients with cortisol secreting adrenal adenomas present with Cushing's syndrome (CS), while 5-15% of subjects with adrenal incidentalomas have subclinical hypercortisolism (SH) as they have biochemical abnormalities suggesting autonomous cortisol secretion without associated clinical features of CS.
Examine HPA function immediately after resection of either of these adenomas and utilize the data to decide on initiating glucocorticoid replacement.
ACTH, cortisol, and DHEA-S levels were measured frequently for 8 h after adrenalectomy in 14 patients with CS and 19 others with incidentalomas + SH. Glucocorticoids were withheld before/during surgery and administered 6-8 h postoperatively to those who had cortisol levels of <3 ug/dL (83 nmol/L).
Preoperatively, incidentalomas + SH patients had larger tumors, higher ACTH, and DHEA-S but lower dexamethasone-suppressed serum cortisol levels than those with CS. Postoperatively, ACTH levels increased in both groups: (90.1 ± 31.6; 24.1 ± 14.4 ng/L, respectively; P < 0.001). Postoperative ACTH levels correlated negatively with preoperative Dexamethasone-suppressed cortisol concentrations in both groups. Patients with CS had steeper decline in cortisol concentrations than those with incidentalomas + SH. All patients with CS had hypocortisolemia requiring glucocorticoid therapy for several months, while only 5/19 with incidentalomas + SH had cortisol levels <3 ug/dL;(83 nmol/L) 6-8 h after adrenalectomy and received hydrocortisone replacement therapy for ≤4 weeks.
Surgical stress stimulates HPA function even in patients with hypercortisolemia. Patients with incidentalomas + SH have incomplete HPA suppression that allows more robust response to surgical stress than that observed in patients with CS. HPA assessment immediately after surgical resection of adrenal incidentalomas identified those requiring glucocorticoid replacement before discharge.
分泌皮质醇的肾上腺腺瘤患者表现为库欣综合征 (CS),而 5-15%的偶然发现的肾上腺瘤患者存在亚临床皮质醇增多症 (SH),因为他们存在生化异常提示自主皮质醇分泌,而无 CS 的相关临床特征。
检查这些腺瘤切除后 HPA 功能,并利用数据决定是否开始糖皮质激素替代治疗。
对 14 例 CS 患者和 19 例偶然发现的肾上腺瘤 +SH 患者,在肾上腺切除术后 8 小时内频繁测量 ACTH、皮质醇和 DHEA-S 水平。在手术前/期间停用糖皮质激素,并在术后 6-8 小时给皮质醇水平<3μg/dL(83nmol/L)的患者使用。
术前,偶然发现的肾上腺瘤 +SH 患者的肿瘤更大,ACTH 和 DHEA-S 更高,但地塞米松抑制后的血清皮质醇水平更低。术后两组 ACTH 水平均升高:(分别为 90.1±31.6;24.1±14.4ng/L;P<0.001)。术后 ACTH 水平与两组术前地塞米松抑制后的皮质醇浓度呈负相关。CS 患者的皮质醇浓度下降比偶然发现的肾上腺瘤 +SH 患者更陡峭。所有 CS 患者均出现皮质醇减少症,需要接受糖皮质激素治疗数月,而仅有 5/19 例偶然发现的肾上腺瘤 +SH 患者在肾上腺切除术后 6-8 小时皮质醇水平<3μg/dL(83nmol/L),并接受了≤4 周的氢化可的松替代治疗。
手术应激刺激 HPA 功能,即使在皮质醇增多症患者中也是如此。偶然发现的肾上腺瘤 +SH 患者的 HPA 抑制不完全,允许对手术应激产生比 CS 患者更强的反应。术后立即评估 HPA 功能可以确定那些在出院前需要糖皮质激素替代治疗的患者。